Olinvacimab (Anti-VEGFR2 / KDR / CD309)
A2979
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameOlinvacimab (Anti-VEGFR2 / KDR / CD309)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionOlinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD
- Storage Instruction-20°C
- UNSPSC12352203